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Cerebrospinal fluid chitotriosidase concentration reflects microglial activation in the spinal cord of in amyotrophic lateral sclerosis patients.
Chitin is a long chain insoluble carbohydrate polymer that is one of the most abundant organic materials in the biosphere, second only to cellulose. 1 It occurs as a key structural molecule in the exoskeleton of invertebrates and cell walls of fungi. It builds up the shells of oysters and clams. Its durable properties are the subject of intense study in biotechnology and materials science. There has been a long-standing assumption that chitin plays no role in vertebrate biology, but this is starting to change; expression of chitin in vertebrate tissues has been verified and potential biological functions of the polymer in higher organisms are just being unravelled. 1
Chitinases constitute a widely expressed family of hydrolases that cleave chitins. Insects produce chitinases to facilitate moulting. Microorganisms produce them to digest nutrients.
The function of chitinases in vertebrates remains unclear, but potentially they play a role in the innate immune system defense against, e.g., fungi and bacteria. The first human chitinase to be cloned and characterised was chitotriosidase, also known as chitinase 1, CHIT1 or ChT.
The gene (CHIT1) is found on chromosome 1 and encodes a neutral-acting glycosyl hydrolase that is expressed in monocytes and macrophages and, hence, also in miroglia (the resident macrophages of the central nervous system [CNS]). Activation of macrophages and microglia results in increased expression and secretion of chitotriosidase. There are also chitinase-like proteins that bind chitin but lack enzymatic activity. A well-studied member of the chitinaselike protein family is YKL-40.
Although the biological function of chitotriosidase in humans remains elusive, the enzyme has been explored as a potential biomarker for macrophage and/or microglial activation. Patients with Gaucher's disease, an inherited lysosomal storage disease, have macrophages engorged with lysosomal glucocerebroside. In response to this, the macrophages secrete enormous amounts of chitotriosidase; a patient with Gaucher's disease may have a 1000-fold increase in the blood level of the protein compared with normal controls. This can be used both as a diagnostic biomarker and as a marker to follow the effect of treatment.
In neurodegenerative diseases, most studies on microglial biomarkers have been performed in well as both neurologically healthy controls and ALS mimics. 3 There was a striking increase in CSF chitotriosidase concentration (measured by enzyme-linked immunosorbent assay; there are also assays for chitotriosidase activity but for those one needs to take a common CHIT1 polymorphism that renders the enzyme inactive into account 4 
